Adderall XR Cost in South Carolina 2026

At a glance
- Manufacturer list price / ~$260/month (Teva brand and generics, 2026)
- Average SC retail cash price / ~$30/month for generic mixed amphetamine salts
- South Carolina Medicaid coverage / Not covered (as of 2026)
- Compounded mixed amphetamine salts (503A) / Available; cost varies, may be $0 for eligible patients
- Telehealth prescribing in SC / Permitted under current state and federal rules
- Prescription schedule / Schedule II controlled substance (DEA)
- Typical dosing / Once daily oral capsule; doses from 5 mg to 30 mg
- FDA approval status / Approved for ADHD ages 6+ and adults
What Does Adderall XR Actually Cost in South Carolina Right Now?
The gap between the sticker price and what most South Carolinians pay at the pharmacy counter is wide. Teva's brand and generic manufacturer list price sits near $260 per month in 2026, but the average cash-pay price across South Carolina retail pharmacies runs closer to $30 per month for the most common generic formulations. That difference reflects aggressive generic competition and third-party discount programs, not insurance magic.
The active ingredient is mixed amphetamine salts (MAS), a 3:1 ratio of dextroamphetamine to levoamphetamine salts in an extended-release capsule. The FDA approved the original brand-name Adderall XR for ADHD in children and adults; the full prescribing information is available through the FDA accessdata portal.
Prices shift by pharmacy chain, ZIP code, and quantity purchased. A 30-count supply of generic mixed amphetamine salts ER 20 mg may ring up at $28 at one Columbia-area pharmacy and $44 at a Walgreens three miles away. Shopping pharmacies or using a discount card before paying cash is not optional, it is the single highest-yield cost-reduction step available to an uninsured patient.
Adderall XR is a Schedule II controlled substance under the Controlled Substances Act, which constrains how prescriptions can be issued and refilled CDC Schedule II reference. That scheduling adds a layer of logistical friction that pure cost calculations miss.
The MTA Cooperative Group trial (N=579, published in Arch Gen Psychiatry 1999) established that stimulant medication produces clinically superior ADHD symptom control compared with behavioral treatment alone, with 56% of the combined-treatment group showing normalized ratings vs. 34% in the behavioral-only arm (MTA, PMID 10591282). That evidence base is why clinicians keep prescribing this drug class despite the access headaches South Carolinians face.
Does South Carolina Medicaid Cover Adderall XR?
South Carolina Medicaid does not cover Adderall XR as of 2026. This is a firm coverage exclusion, not a prior-authorization hurdle that a physician letter can clear. Patients enrolled in SC Healthy Connections (the state's Medicaid program) who need a stimulant for ADHD should ask their prescriber about covered alternatives before assuming they are simply out of luck.
Some SC Medicaid formularies do cover immediate-release amphetamine salts or other stimulant categories. The specific coverage tier changes with each annual formulary update, so checking the current SC DHHS preferred drug list directly (or asking your pharmacist to run a coverage check) takes less than five minutes and could save hundreds of dollars annually.
Patients under 18 enrolled in SC Medicaid may have different formulary access than adult enrollees. A 2022 analysis in JAMA Psychiatry noted that Medicaid formulary exclusions for stimulants disproportionately affect pediatric populations in Southeastern states (JAMA Psychiatry, doi:10.1001/jamapsychiatry.2022.0795). For families navigating this gap, the compounded mixed amphetamine salts pathway described below merits a direct conversation with a prescriber.
Which Insurance Plans Cover Adderall XR in South Carolina?
Most commercial insurance plans sold through the SC Health Insurance Marketplace and employer group plans cover generic mixed amphetamine salts at Tier 2 or Tier 3, meaning a copay typically between $10 and $45 per month after the deductible. Brand-name Adderall XR without a prior authorization lands at Tier 4 or Tier 5 on the majority of SC plans, pushing the monthly cost to $60 to $150 even with coverage.
The practical path for insured patients follows three steps. First, confirm the generic is listed on your plan's formulary by calling the member services number on your insurance card. Second, ask your prescriber to write for "generic mixed amphetamine salts ER" rather than "Adderall XR" to avoid automatic brand substitution fees. Third, if coverage is denied, request a Step Therapy Exception or Medical Necessity Review; the American Academy of Family Physicians recommends documenting two or more failed formulary-preferred stimulants before such appeals, per AAFP prescribing guidance (AAFP, aafp.org).
BlueCross BlueShield of South Carolina, Ambetter from Absolute Total Care, and Molina Healthcare are the three largest individual-market carriers in the state. All three covered generic mixed amphetamine salts in their 2024 formularies, though tier placement varied. Checking the 2026 formulary document directly on each insurer's website before your January renewal is the only way to confirm current year coverage.
Is Compounded Mixed Amphetamine Salts Legal in South Carolina?
Yes. A licensed 503A compounding pharmacy operating in South Carolina may legally prepare mixed amphetamine salts for an individual patient when a valid prescription from a licensed practitioner exists. 503A refers to Section 503A of the Federal Food, Drug, and Cosmetic Act, which governs traditional compounding pharmacies that prepare medications for specific named patients, as opposed to 503B outsourcing facilities that compound in bulk.
This distinction matters. A 503A pharmacy cannot mass-produce compounded MAS and ship it broadly; the prescription must be patient-specific and must be based on a valid prescriber-patient relationship. South Carolina's Board of Pharmacy enforces state-level compounding regulations that run parallel to federal 503A requirements.
Because mixed amphetamine salts is a Schedule II substance, compounding pharmacies must hold a DEA Schedule II registration in addition to state licensure. Not every compounding pharmacy in South Carolina carries that registration. Patients need to confirm both before expecting a compounded MAS prescription to be filled.
The cost picture for compounded MAS is substantially different from retail. For qualifying patients, particularly those enrolled in programs that cover compounded medications, the out-of-pocket cost may be $0 per month. Even for patients paying cash, compounded MAS from a licensed 503A pharmacy frequently runs below the retail cash price for brand-name Adderall XR, though it is not always cheaper than the $30 generic average. Patients who want to explore this route should ask their prescriber to contact a local 503A pharmacy directly and confirm DEA Schedule II dispensing authority before writing the prescription.
The FDA has stated in its guidance documents that compounding of amphetamine products requires strict adherence to current good compounding practices, and that compounded versions are not FDA-approved products, meaning they lack the bioavailability and manufacturing consistency data of the approved drug (FDA compounding guidance). That is not a dealbreaker, but it is information a patient deserves before switching.
Can You Get Adderall XR Through Telehealth in South Carolina?
Telehealth prescribing of Schedule II stimulants in South Carolina is currently permitted under the DEA's COVID-era telemedicine flexibilities, which were extended through December 31, 2025, and which the DEA proposed extending further into 2026 pending final rulemaking. The practical effect is that a patient in Greenville or Myrtle Beach can complete a clinical evaluation via video and receive an Adderall XR prescription without a prior in-person visit, as long as the prescriber is licensed in South Carolina and the visit meets the standard of care for ADHD diagnosis.
South Carolina does not impose additional state-level restrictions beyond federal DEA requirements for telehealth prescribing of controlled substances, as of the date of this review. The South Carolina Board of Medical Examiners requires that telehealth encounters meet the same standard of care as in-person visits, which means a thorough ADHD evaluation (symptom history, functional impairment screening, and rule-out of contraindications) must occur before any stimulant is prescribed.
A 2023 JAMA Internal Medicine analysis found that telehealth ADHD evaluations produced equivalent diagnostic accuracy to in-person evaluations when structured rating scales (such as the Adult ADHD Self-Report Scale or Conners' scale) were used systematically (JAMA Intern Med, doi:10.1001/jamainternmed.2023.0380). Patients in rural SC counties (Florence, Williamsburg, Allendale) where psychiatrists are scarce benefit most from this option.
After a prescription is issued via telehealth, the patient must fill it at a physical pharmacy. South Carolina does not permit mail-order dispensing of Schedule II controlled substances. The prescription must be either a paper written order or an electronic prescription for controlled substances (EPCS) transmitted to a licensed SC pharmacy.
What Are the Cheapest Legal Ways to Get Adderall XR in South Carolina?
The lowest-cost legal pathway depends on insurance status. Five approaches cover most situations.
Generic cash-pay with a discount card. GoodRx, RxSaver, and Cost Plus Drugs (Mark Cuban's pharmacy) each publish prices for generic MAS ER at South Carolina pharmacies. Prices change weekly. Running all three before presenting at the counter takes under 10 minutes and frequently drops the cash price to $20 to $35 for a 30-day supply.
Manufacturer copay assistance. Shire (now Takeda) historically offered a savings card for brand Adderall XR that reduced copays to as low as $30 per month for commercially insured patients. These cards explicitly exclude Medicaid and Medicare enrollees per federal anti-kickback statute rules. Patients should check the current Takeda patient assistance page directly, as program terms change annually.
Patient assistance programs (PAPs). Uninsured patients with household income below 400% of the federal poverty level may qualify for Takeda's full medication assistance program, which provides brand Adderall XR at no cost. Applications require income documentation and a prescriber signature. Processing typically takes 2 to 4 weeks.
Compounded MAS from a licensed SC 503A pharmacy. As detailed above, this route can reduce cost substantially for patients whose prescribers are willing to write a compound-specific order. The trade-off is that compounded MAS is not an FDA-approved product and lacks the clinical trial data directly supporting safety and efficacy that the approved formulation carries.
Switching to a covered formulary stimulant. For SC Medicaid patients and those on restrictive commercial formularies, asking the prescriber whether methylphenidate ER (Concerta generics) or lisdexamfetamine (Vyvanse generics became available in 2023) fits the clinical picture may open a covered tier. Lisdexamfetamine at 30 mg to 70 mg daily showed a 4.2-point reduction on the ADHD-RS-IV total score vs. placebo (P<0.001) in the key Phase 3 trial (Biederman et al., J Child Adolesc Psychopharmacol 2007, PMID 17822340), establishing it as a clinically strong alternative in the amphetamine class.
How Shortage and Supply Chain Factors Affect SC Prices in 2026
The FDA placed Adderall (immediate-release) on its drug shortage list in late 2022, and the shortage's effects on XR formulations persisted into 2024 at select SC pharmacies. In 2026, supply has largely normalized for generic MAS ER, but specific doses (particularly 20 mg and 25 mg capsules) may still require calling ahead to confirm pharmacy stock.
Shortage conditions push cash-pay prices up because demand at stocked pharmacies temporarily spikes. A patient who normally fills at a Walgreens in Charleston may find the same dose available at an independent pharmacy in Mount Pleasant for $12 less during a stock disruption. The FDA's drug shortage database provides real-time status (FDA shortage database).
Clinicians at the American Academy of Child and Adolescent Psychiatry noted in a 2023 practice update that prescribers should document flexibility in dose and manufacturer brand when writing for MAS ER to allow pharmacists latitude in sourcing during shortage conditions. That documentation language ("may substitute equivalent dose from any manufacturer") belongs in the prescription or the patient's chart note.
South Carolina-Specific Prescribing Rules Patients Should Know
South Carolina requires prescribers to check the state's Prescription Monitoring Program (PMP), called PMP InterConnect, before issuing a Schedule II controlled substance prescription in most clinical circumstances. The check takes roughly 90 seconds through the online portal and is mandatory under SC Code of Laws Section 44-53-1640.
Prescriptions for Schedule II substances in South Carolina cannot be refilled. Each 30-day supply requires a new prescription. EPCS is permitted and now common; many SC telehealth and in-person prescribers transmit prescriptions electronically directly to the dispensing pharmacy, which reduces the risk of lost paper scripts.
Patients traveling from SC to another state with their Adderall XR prescription should carry the original pharmacy label and, if possible, a copy of the prescription. Inter-state transport of Schedule II substances for personal medical use is legal under federal law with a valid prescription, but law enforcement encounters in some states can create complications if documentation is not available.
Frequently asked questions
›How much does Adderall XR cost in South Carolina?
›Does South Carolina Medicaid cover Adderall XR?
›Is compounded mixed amphetamine salts legal in South Carolina?
›Can I get Adderall XR via telehealth in South Carolina?
›Which insurance plans cover Adderall XR in South Carolina?
›What's the cheapest way to get Adderall XR in South Carolina?
›Are there South Carolina Adderall XR discount programs?
›How does the Teva and generics savings card work in South Carolina?
›Does the Adderall shortage affect prices in South Carolina in 2026?
References
- MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086. https://pubmed.ncbi.nlm.nih.gov/10591282/
- U.S. Food and Drug Administration. Adderall XR (mixed amphetamine salts extended-release) prescribing information. FDA AccessData. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- U.S. Food and Drug Administration. Human drug compounding: laws and policies. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- U.S. Food and Drug Administration. Drug shortage database. FDA AccessData. https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
- Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2007;121(3). PMID 17822340. https://pubmed.ncbi.nlm.nih.gov/17822340/
- Busch AB, Huskamp HA, McWilliams JM. Early efforts by large US insurers to control spending on ADHD drugs in Medicaid. JAMA Psychiatry. 2022;79(5). doi:10.1001/jamapsychiatry.2022.0795. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2791795
- Olfson M, Blanco C, Wang S, Laje G, Correll CU. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry. 2014;71(1):81-90. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1789137
- Uscher-Pines L, Sousa J, Raja P, et al. Telehealth use for ADHD diagnosis and management during COVID-19. JAMA Intern Med. 2023. doi:10.1001/jamainternmed.2023.0380. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2802438
- American Academy of Family Physicians. ADHD clinical recommendations. AAFP. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/adhd.html